Ab mere paas sab kuch hai. Ab complete, detailed notes likhta hoon!---
๐ฌ CARBOHYDRATE METABOLISM - Complete MBBS Notes
Simple English | Textbook-Based | Exam-Ready
Sources: Lippincott Illustrated Biochemistry 8e | Basic Medical Biochemistry 6e | Harper's Biochemistry 32e
๐ TABLE OF CONTENTS
- Glucose Transport (GLUTs & SGLTs)
- Glycolysis - All 10 Steps in Detail
- Pyruvate's Fate - Aerobic vs Anaerobic
- Pyruvate Dehydrogenase Complex (PDC)
- TCA Cycle / Krebs Cycle - All 8 Steps
- Oxidative Phosphorylation & ETC
- Total ATP Yield
- Gluconeogenesis
- Glycogen Metabolism
- Pentose Phosphate Pathway (HMP Shunt)
- Cori Cycle & Glucose-Alanine Cycle
- Clinical Conditions - All High-Yield Diseases
PART 1: GLUCOSE TRANSPORT INTO CELLS
Glucose is a big, polar molecule - it cannot just slip through the fat-based cell membrane. It needs special transport proteins.
A. GLUT Transporters (Facilitated Diffusion - FREE, no ATP needed)
These are like revolving doors. Glucose binds on one side, protein changes shape, glucose enters. One glucose at a time = uniporter.
| GLUT | Location | Km (mM) | Special Feature |
|---|
| GLUT-1 | RBCs, brain, most tissues | 1 (high affinity) | Basal uptake; always active |
| GLUT-2 | Liver, kidney, pancreas ฮฒ-cells | 15-20 (low affinity) | High capacity; glucose sensor in pancreas |
| GLUT-3 | Brain neurons, most tissues | 1 (high affinity) | Ensures brain gets glucose even when low |
| GLUT-4 | Muscle, adipose tissue | 5 | Insulin-dependent! Stored in vesicles, moves to surface with insulin |
| GLUT-5 | Small intestine, testes | 10 | Mainly transports fructose (not glucose) |
Key concept - Why low Km = high affinity?
Low Km means the transporter gets half-saturated at very low glucose concentrations - so it works efficiently even when blood glucose is low. GLUT-1 in the brain ensures the brain never runs out of glucose.
Why GLUT-2 has high Km?
Because liver and pancreas are glucose "sensors." They only react/work when blood glucose is genuinely high (after meals). They are not meant for "always-on" low-level uptake.
B. SGLT Transporters (Active Transport - needs Na+ gradient)
Used in: intestinal epithelium (absorbs dietary glucose) and renal tubules (reabsorbs filtered glucose).
Mechanism: Na+ flows down its concentration gradient INTO the cell and drags glucose along with it (symport). Both move in same direction. Na+/K+ ATPase maintains the low intracellular Na+, so ATP is indirectly needed.
Clinical: SGLT-2 inhibitors (Gliflozins) - e.g., Empagliflozin, Dapagliflozin
- Block glucose reabsorption in kidney proximal tubule
- Glucose spills into urine โ lowers blood glucose
- Used in Type 2 Diabetes; also reduces cardiovascular events and protects kidneys
PART 2: GLYCOLYSIS - ALL 10 STEPS IN DETAIL
Location: Cytosol (cytoplasm)
Occurs in: ALL cells (even RBCs which have no mitochondria)
Key concept: 1 glucose (6 carbons) โ 2 pyruvate (3 carbons each)
PHASE 1: Energy-Investment Phase (Steps 1-5)
"Spend 2 ATP to prime the pump"
Step 1 - Glucose โ Glucose-6-Phosphate (G6P)
Enzyme: Hexokinase (most tissues) OR Glucokinase / Hexokinase IV (liver & pancreas)
Uses: 1 ATP
Why irreversible: Phosphorylation traps glucose inside the cell. G6P cannot leave through GLUT transporters.
Hexokinase vs Glucokinase - Very Important Difference:
| Feature | Hexokinase (I-III) | Glucokinase (Hexokinase IV) |
|---|
| Where | All tissues | Liver + Pancreatic ฮฒ-cells |
| Km for glucose | Low (~0.1 mM) - high affinity | High (~10 mM) - low affinity |
| Vmax | Low | High |
| Inhibited by G6P? | YES (product inhibition) | NO (no feedback inhibition) |
| Induced by insulin? | NO | YES |
Why does this matter clinically?
- Hexokinase: Works even at low glucose - always phosphorylates glucose. But once cells are full (G6P builds up), it stops automatically.
- Glucokinase: Only activates when blood glucose is HIGH (after a meal). Acts as a glucose-sensor in the pancreas - triggers insulin secretion. In liver, it clears excess blood glucose rapidly. Mutations in glucokinase โ MODY (Maturity Onset Diabetes of the Young) Type 2.
Step 2 - Glucose-6-P โ Fructose-6-P
Enzyme: Phosphoglucose Isomerase
Type: Isomerization (aldose to ketose)
Reversible
Step 3 - Fructose-6-P โ Fructose-1,6-bisphosphate (F1,6-bisP)
Enzyme: Phosphofructokinase-1 (PFK-1)
Uses: 1 ATP
Irreversible - This is the RATE-LIMITING STEP of glycolysis
PFK-1 Regulation:
| Inhibitors (slow down glycolysis) | Activators (speed up glycolysis) |
|---|
| ATP (high energy state) | AMP, ADP (low energy state) |
| Citrate (TCA intermediates are full) | Fructose-2,6-bisphosphate (most potent!) |
| H+ (acidosis) | NH4+ |
What is Fructose-2,6-bisphosphate (F2,6-bisP)?
This is a separate molecule (NOT a glycolysis intermediate) made by the enzyme PFK-2 (bifunctional enzyme):
- Insulin โ activates PFK-2 โ F2,6-bisP increases โ PFK-1 activated โ glycolysis ON
- Glucagon โ inhibits PFK-2 / activates F2,6-bisPhosphatase โ F2,6-bisP decreases โ PFK-1 inhibited โ glycolysis OFF, gluconeogenesis ON
This is how insulin and glucagon control glycolysis!
Step 4 - Fructose-1,6-bisP โ DHAP + Glyceraldehyde-3-P (GAP)
Enzyme: Aldolase
Type: Aldol cleavage - splits the 6C molecule into two 3C molecules
Products:
- Dihydroxyacetone phosphate (DHAP) - can go to glycerol-3-P (for fat synthesis)
- Glyceraldehyde-3-phosphate (GAP) - continues in glycolysis
Step 5 - DHAP โ GAP
Enzyme: Triose Phosphate Isomerase
Why: DHAP cannot continue in glycolysis, so it gets converted to GAP
Result: 2 GAP molecules now continue (both from one glucose)
From step 6 onwards, everything happens TWICE (once for each GAP)
PHASE 2: Energy-Generation Phase (Steps 6-10)
"Make 4 ATP + 2 NADH (net gain = 2 ATP)"
Step 6 - GAP โ 1,3-bisphosphoglycerate (1,3-BPG)
Enzyme: Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)
Makes: NADH
Important:
- This is an oxidation-reduction reaction - NAD+ is reduced to NADH
- The energy of oxidation is conserved in the high-energy phosphate bond of 1,3-BPG
- Arsenate (pentavalent arsenic) poisons this step: competes with phosphate, forms unstable product โ bypasses ATP generation โ no net ATP from glycolysis!
- This step REQUIRES NAD+. If NAD+ runs out, glycolysis stops - that's why in anaerobic conditions, pyruvate must be converted to lactate to regenerate NAD+
Step 7 - 1,3-BPG โ 3-Phosphoglycerate (3-PG)
Enzyme: Phosphoglycerate Kinase
Makes: 1 ATP (per GAP = 2 ATP total)
Type: Substrate-level phosphorylation (ATP made directly, not via ETC)
2,3-BPG (Important for MBBS!):
Some 1,3-BPG can be converted to 2,3-BPG by bisphosphoglycerate mutase (in RBCs).
- 2,3-BPG binds to hemoglobin and DECREASES its affinity for O2 (shifts oxygen dissociation curve RIGHT)
- This promotes O2 release to tissues
- High altitude, anemia, chronic hypoxia โ increased 2,3-BPG โ more O2 delivery to tissues
Step 8 - 3-PG โ 2-Phosphoglycerate (2-PG)
Enzyme: Phosphoglycerate Mutase
Type: Intramolecular phosphate transfer (isomerization)
Step 9 - 2-PG โ Phosphoenolpyruvate (PEP)
Enzyme: Enolase
Reaction: Dehydration (removes water)
Makes: PEP, which has a very high-energy phosphate bond
Inhibitor: Fluoride (Fโป) inhibits enolase. That's why blood glucose samples are collected in fluoride oxalate tubes - fluoride stops glycolysis so glucose doesn't get consumed before measurement!
Step 10 - PEP โ Pyruvate
Enzyme: Pyruvate Kinase
Makes: 1 ATP (per GAP = 2 ATP total)
Irreversible - 3rd regulatory enzyme of glycolysis
Pyruvate Kinase Regulation:
- Activated by: Fructose-1,6-bisP (feedforward activation - PFK-1 goes up, so PK goes up), insulin
- Inhibited by: ATP, acetyl-CoA, alanine, glucagon (via phosphorylation)
Clinical: Pyruvate Kinase Deficiency
- Most common enzyme defect of glycolysis
- RBCs cannot make ATP โ RBC membrane fails โ Hemolytic Anemia
- Unlike G6PD deficiency, NOT triggered by oxidative stress; it's chronic
Glycolysis Summary
| What's spent | Amount |
|---|
| ATP (steps 1 & 3) | -2 ATP |
| What's made | Amount |
|---|
| ATP (steps 7 & 10, ร2) | +4 ATP |
| NADH (step 6, ร2) | +2 NADH |
| Net ATP | +2 ATP |
PART 3: FATE OF PYRUVATE
After glycolysis, pyruvate has 3 possible fates:
โโโโโโ[O2 present]โโโ Acetyl-CoA (via PDC) โโ TCA cycle
โ
2 Pyruvate โโโโโโโค
โ
โโโโโโ[No O2]โโโโโโโโโ Lactate (via LDH)
โ
โโโโโโ[Liver/Kidney]โโโ Glucose (Gluconeogenesis)
PART 4: PYRUVATE DEHYDROGENASE COMPLEX (PDC)
Location: Mitochondrial matrix
Function: Converts pyruvate (3C) โ Acetyl-CoA (2C) + CO2 + NADH
This is an oxidative decarboxylation reaction - you lose one carbon as CO2, and oxidation gives NADH.
This reaction is IRREVERSIBLE - you cannot go back from Acetyl-CoA to pyruvate.
Clinical significance: Fatty acids โ Acetyl-CoA โ but Acetyl-CoA CANNOT become glucose. This is why fat cannot be converted to glucose in the body.
Structure of PDC
PDC is a giant enzyme complex with 3 enzymatic subunits:
| Subunit | Enzyme | Cofactor |
|---|
| E1 | Pyruvate Decarboxylase | TPP (Thiamine - B1) |
| E2 | Dihydrolipoyl Transacetylase | Lipoic acid + CoA |
| E3 | Dihydrolipoyl Dehydrogenase | FAD + NAD+ |
Memory trick for cofactors - "The Lovely Cat Follows Nick":
- Thiamine (B1) - TPP
- Lipoic acid
- CoA (Pantothenate - B5)
- FAD (Riboflavin - B2)
- NAD+ (Niacin - B3)
The reaction sequence:
- E1 (with TPP): Pyruvate loses CO2, remaining 2C fragment binds to TPP
- E2 (with Lipoate): 2C fragment transferred to lipoate, then to CoA โ Acetyl-CoA formed, lipoate reduced
- E3 (with FAD): Reduced lipoate is reoxidized, FAD reduced to FADH2, then FADH2 transfers electrons to NAD+ โ NADH
PDC Regulation (Very Important for MBBS!)
TWO mechanisms:
- Allosteric (fast, instant)
- Covalent modification by phosphorylation (slower)
Allosteric:
- Activated by: AMP, ADP, NAD+, CoA, Ca2+ (during exercise/muscle contraction), insulin
- Inhibited by: Acetyl-CoA (product), NADH (product), ATP (high energy)
Covalent (Phosphorylation):
- PDC Kinase phosphorylates PDC โ INACTIVE (when ATP, acetyl-CoA, NADH are high)
- PDC Phosphatase dephosphorylates PDC โ ACTIVE (when Ca2+, insulin are high)
Memory trick: "Phosphorylation turns OFF PDC; Dephosphorylation turns it ON"
(Opposite of glycogen phosphorylase!)
PDC Deficiency - Clinical
Cause: Usually mutation in E1-alpha subunit gene (X-linked dominant)
Effect: Pyruvate cannot enter TCA cycle โ builds up โ converted to lactate
Result: Lactic acidosis + neurological damage
Symptoms: Seizures, developmental delay, lethargy, lactic acidosis
Treatment: High fat diet (ketogenic - provides acetyl-CoA directly, bypasses PDC)
Other clinical links:
| Deficiency | Effect on PDC |
|---|
| Thiamine (B1) deficiency | E1 cannot work โ PDC fails โ lactic acidosis, Wernicke's encephalopathy |
| Arsenic / Arsenite poisoning | Inactivates lipoic acid (E2) โ PDC fails โ lactic acidosis |
PART 5: TCA CYCLE (Krebs / Citric Acid Cycle) - ALL 8 STEPS
Location: Mitochondrial matrix
Works in: All cells with mitochondria (NOT in RBCs)
Input: 1 Acetyl-CoA (2C) + 1 OAA (4C) โ produces CO2 + energy carriers
Key concept: Oxaloacetate (OAA) is regenerated each turn = it is a catalyst (acts like it)
The 8 Steps of TCA Cycle:
Step 1: OAA (4C) + Acetyl-CoA (2C) โ Citrate (6C)
Enzyme: Citrate Synthase
Type: Condensation (C-C bond formed)
Inhibited by: Citrate, ATP, NADH, Succinyl-CoA
Activated by: ADP, OAA
Step 2: Citrate (6C) โ Isocitrate (6C)
Enzyme: Aconitase (Aconitate Hydratase)
Type: Isomerization (via cis-aconitate intermediate)
Important: Citrate is symmetrical, but aconitase acts asymmetrically. The carbons that leave as CO2 in this turn are NOT the ones that just entered as Acetyl-CoA - they are the old OAA carbons!
Inhibited by: Fluorocitrate (produced from fluoroacetate - a rat poison!)
Step 3: Isocitrate (6C) โ ฮฑ-Ketoglutarate (5C) + CO2
Enzyme: Isocitrate Dehydrogenase
Makes: NADH + CO2
Rate-limiting step of TCA cycle
Inhibited by: NADH, ATP
Activated by: ADP, Ca2+, AMP, isocitrate
Step 4: ฮฑ-Ketoglutarate (5C) โ Succinyl-CoA (4C) + CO2
Enzyme: ฮฑ-Ketoglutarate Dehydrogenase (ฮฑ-KG Dehydrogenase)
Makes: NADH + CO2
Cofactors: Same as PDC! - TPP, Lipoate, CoA, FAD, NAD+ (B1, Lipoic acid, B5, B2, B3)
Inhibited by: Succinyl-CoA, NADH
Inhibited by arsenic (because it uses lipoic acid)
This is the 2nd oxidative decarboxylation; second CO2 is released here.
Step 5: Succinyl-CoA (4C) โ Succinate (4C)
Enzyme: Succinyl-CoA Synthetase
Makes: GTP (= equivalent to ATP) - substrate-level phosphorylation
Also makes: CoA is released (recycled)
This is the only step that directly makes a high-energy phosphate in TCA
Step 6: Succinate (4C) โ Fumarate (4C)
Enzyme: Succinate Dehydrogenase
Makes: FADH2 (not NADH - because the energy difference is not enough to reduce NAD+)
Location: Inner mitochondrial membrane (only TCA enzyme in membrane, part of Complex II of ETC)
Inhibited by: Malonate (competitive inhibitor, structural analog of succinate - used in research)
Step 7: Fumarate (4C) โ Malate (4C)
Enzyme: Fumarase (Fumarate Hydratase)
Type: Hydration (adds water)
Fumarate is a trans compound; malate formed is L-malate (stereospecific)
Step 8: Malate (4C) โ Oxaloacetate (4C)
Enzyme: Malate Dehydrogenase
Makes: NADH
OAA is regenerated - cycle can start again!
Important: This reaction is thermodynamically unfavorable (high positive ฮG) under most conditions. It is driven forward by the consumption of OAA in Step 1 (citrate synthase pulls the reaction)
Per Turn Summary:
| Product | Amount |
|---|
| NADH | 3 (steps 3, 4, 8) |
| FADH2 | 1 (step 6) |
| GTP | 1 (step 5) |
| CO2 | 2 (steps 3, 4) |
Per glucose (2 turns of TCA) = 6 NADH + 2 FADH2 + 2 GTP + 4 CO2
TCA Cycle Regulation
TCA cycle is regulated mainly at 3 points:
- Citrate Synthase - inhibited by citrate, NADH, ATP, succinyl-CoA
- Isocitrate Dehydrogenase - inhibited by NADH, ATP; activated by ADP, Ca2+
- ฮฑ-KG Dehydrogenase - inhibited by succinyl-CoA, NADH; activated by Ca2+
Overall principle: When energy is high (ATP, NADH high), TCA slows down. When energy is low (ADP, AMP high), TCA speeds up.
Anaplerosis & Cataplerosis
Anaplerosis = refilling TCA cycle intermediates (so the cycle keeps going)
- Main reaction: Pyruvate + CO2 โ OAA (enzyme: Pyruvate Carboxylase, needs biotin)
- Amino acids also feed in at various points
Cataplerosis = removing intermediates from TCA cycle (for biosynthesis)
- OAA โ PEP (for gluconeogenesis)
- ฮฑ-Ketoglutarate โ Glutamate (for amino acid synthesis)
- Succinyl-CoA โ Heme synthesis
Key rule: Anaplerosis must equal cataplerosis to sustain the cycle
PART 6: OXIDATIVE PHOSPHORYLATION & ELECTRON TRANSPORT CHAIN (ETC)
Location: Inner mitochondrial membrane
Function: Uses NADH and FADH2 energy to make ATP
Requires: Oxygen (O2) as final electron acceptor
The 4 Complexes
| Complex | Name | Accepts | Pumps H+? | Clinical |
|---|
| Complex I | NADH-CoQ oxidoreductase | NADH | Yes (4 H+) | Inhibited by rotenone, metformin |
| Complex II | Succinate dehydrogenase | FADH2 | NO | Inhibited by malonate |
| Complex III | Cytochrome b-c1 complex | CoQ (Ubiquinol) | Yes (4 H+) | Inhibited by antimycin A |
| Complex IV | Cytochrome c oxidase | Cytochrome c | Yes (2 H+) | Inhibited by cyanide, CO, azide |
Electron flow: NADH โ Complex I โ CoQ โ Complex III โ Cyt c โ Complex IV โ O2 โ H2O
FADH2 flow: FADH2 โ Complex II โ CoQ โ Complex III โ (same as above)
Chemiosmotic Theory (Peter Mitchell, Nobel Prize 1978)
- As electrons flow through Complexes I, III, IV, protons (H+) are pumped OUT of the mitochondrial matrix into the intermembrane space
- This creates an electrochemical gradient (proton motive force, ฮp) across the inner membrane
- Protons want to flow back into the matrix (down their gradient)
- They can only re-enter through ATP Synthase (Complex V / F0F1-ATPase)
- As protons flow through ATP synthase, it rotates (like a turbine) and generates ATP from ADP + Pi
ATP Yield per NADH vs FADH2
- 1 NADH โ ~2.5 ATP (passes through Complexes I, III, IV - pumps 10 H+)
- 1 FADH2 โ ~1.5 ATP (bypasses Complex I, only pumps 6 H+ through Complexes III & IV)
Inhibitors of ETC - Clinical Importance
| Poison/Drug | Blocks | Effect |
|---|
| Cyanide (KCN) | Complex IV | Cells cannot use O2 โ cells die despite O2 being present |
| Carbon monoxide (CO) | Complex IV (also Hb) | Same as cyanide; headache, coma, death |
| Rotenone | Complex I | Insecticide; also caused Parkinsonism in farmers |
| Metformin (diabetes drug) | Complex I (mildly) | Reduces NADH oxidation โ less gluconeogenesis |
| Oligomycin | ATP Synthase | Stops ATP synthesis; stops electron flow (coupled) |
Uncouplers - Separate Proton Flow from ATP Synthesis
Uncouplers allow H+ to re-enter matrix WITHOUT going through ATP synthase. Energy is lost as heat instead of ATP.
| Uncoupler | Details |
|---|
| 2,4-DNP (dinitrophenol) | Industrial chemical; causes weight loss, fatal hyperthermia |
| Thermogenin (UCP-1) | Brown adipose tissue; newborn infants use it to generate heat |
| Aspirin (high dose) | Mild uncoupling |
PART 7: TOTAL ATP YIELD FROM 1 GLUCOSE
| Stage | Product | ATP Yield |
|---|
| Glycolysis | 2 ATP (substrate level) | 2 ATP |
| Glycolysis | 2 NADH ร 2.5 ATP | 5 ATP |
| PDC (2 turns) | 2 NADH ร 2.5 ATP | 5 ATP |
| TCA Cycle (2 turns) | 6 NADH ร 2.5 ATP | 15 ATP |
| TCA Cycle (2 turns) | 2 FADH2 ร 1.5 ATP | 3 ATP |
| TCA Cycle (2 turns) | 2 GTP | 2 ATP |
| TOTAL | | ~30-32 ATP |
Note: Old textbooks quoted 36-38 ATP. Modern calculation gives 30-32 because mitochondrial transport costs (moving pyruvate in, ATP out) reduce the yield slightly.
Aerobic vs Anaerobic:
- Aerobic: ~30-32 ATP per glucose
- Anaerobic (no O2): Only 2 ATP per glucose (only glycolysis works)
PART 8: GLUCONEOGENESIS - Making Glucose from Scratch
Definition: Synthesis of glucose from non-carbohydrate precursors
Location: Mainly liver (90%), some kidney cortex (10%, increases during prolonged fasting)
When: During fasting, starvation, prolonged exercise, or after low-carb diet
The 4 Main Precursors
| Precursor | Source | Where it enters |
|---|
| Lactate | RBCs, exercising muscle | โ Pyruvate (via LDH) |
| Glycerol | Adipose tissue (fat breakdown) | โ DHAP (enters glycolysis) |
| Alanine | Muscle protein breakdown | โ Pyruvate (via transamination) |
| Glucogenic amino acids | Most amino acids (except Leu, Lys) | Various TCA intermediates |
Note: Fatty acids (except odd-chain fatty acids) cannot become glucose. Even-chain fatty acids โ Acetyl-CoA โ TCA cycle only (cannot become glucose because there is no net carbon addition to OAA from Acetyl-CoA after 2 CO2 are lost).
The 3 Bypass Steps (Most Important!)
Gluconeogenesis is glycolysis run in REVERSE - but 3 steps are irreversible in glycolysis and need special bypass enzymes:
Bypass 1: Pyruvate โ PEP (Replaces Pyruvate Kinase)
Two-step process:
Step A: Pyruvate โ OAA (in mitochondria)
- Enzyme: Pyruvate Carboxylase (requires Biotin + ATP)
- Activated by: Acetyl-CoA
- Note: Acetyl-CoA activating pyruvate carboxylase is clever - when fat is being burned (lots of Acetyl-CoA), body says "also make glucose from pyruvate"
Step B: OAA โ PEP (in cytoplasm)
- Enzyme: PEPCK (Phosphoenolpyruvate Carboxykinase) (needs GTP, releases CO2)
- OAA is transported out of mitochondria as malate (since OAA cannot cross the membrane)
- Induced by: Glucagon, cortisol, fasting โ makes gluconeogenesis go
Memory: "Pyruvate โ (Pyruvate Carboxylase) โ OAA โ (PEPCK) โ PEP"
Bypass 2: Fructose-1,6-bisP โ Fructose-6-P (Replaces PFK-1)
Enzyme: Fructose-1,6-bisPhosphatase (FBPase-1)
- Simply removes the phosphate from position 1 by hydrolysis
- Inhibited by: AMP, Fructose-2,6-bisphosphate (when fed state = glycolysis ON = gluconeogenesis OFF)
- Activated by: ATP, citrate
Bypass 3: Glucose-6-P โ Glucose (Replaces Hexokinase)
Enzyme: Glucose-6-Phosphatase
- Located in ER membrane of liver and kidney only
- Muscle CANNOT release free glucose (no glucose-6-phosphatase) - muscle glycogen stays in muscle
- In liver, releases free glucose into blood to maintain blood glucose levels
Gluconeogenesis Regulation (Summary)
| Hormone/Signal | Effect on Gluconeogenesis |
|---|
| Glucagon (fasting) | ACTIVATES (induces PEPCK, FBPase; inactivates PFK-1 via F2,6-bisP) |
| Insulin (fed) | INHIBITS |
| Cortisol | ACTIVATES (induces enzymes - important in stress) |
| Adrenaline (exercise) | ACTIVATES |
| AMP | INHIBITS (low energy โ don't waste ATP making glucose) |
| Acetyl-CoA | ACTIVATES (activates Pyruvate Carboxylase - step 1) |
Energy Cost of Gluconeogenesis
Making 1 glucose from 2 pyruvate costs: 6 ATP (4 ATP + 2 GTP)
This is why gluconeogenesis requires energy - the liver uses fat oxidation to supply this energy during fasting.
PART 9: GLYCOGEN METABOLISM
Glycogen = polymer of glucose, stored in liver (for blood glucose) and muscle (for local energy)
Structure:
- Glucose units linked by ฮฑ-1,4-glycosidic bonds (straight chain)
- Branch points: ฮฑ-1,6-glycosidic bonds every 8-10 residues
- Branching increases solubility and allows rapid mobilization from many chain ends simultaneously
GLYCOGENESIS (Synthesis)
Steps:
- Glucose โ Glucose-6-P (Hexokinase/Glucokinase)
- Glucose-6-P โ Glucose-1-P (Phosphoglucomutase)
- Glucose-1-P + UTP โ UDP-Glucose + PPi (UDP-glucose pyrophosphorylase)
- UDP-glucose is the "activated" form of glucose - the "building block"
- PPi (pyrophosphate) is hydrolyzed to 2Pi by pyrophosphatase โ drives reaction forward
- UDP-Glucose added to glycogen chain (Glycogen Synthase - key enzyme, adds ฮฑ-1,4 links)
- Branching Enzyme (Amylo-4,6-transglycosylase): moves a block of 6-7 residues from end of chain to form a new ฮฑ-1,6 branch
Glycogenin: The primer protein. Glycogen synthesis STARTS on glycogenin. First few glucose molecules are attached to it, then glycogen synthase takes over.
Activated by: Insulin (activates glycogen synthase via phosphatase), glucose (in liver)
Inhibited by: Glucagon, epinephrine (via cAMP/PKA โ phosphorylate and INACTIVATE glycogen synthase)
GLYCOGENOLYSIS (Degradation)
Steps:
- Glycogen Phosphorylase cleaves ฮฑ-1,4 bonds from the non-reducing ends โ Glucose-1-P (NOT free glucose - phosphate comes from Pi, not water)
- But phosphorylase STOPS 4 residues from a branch point. Then:
- Debranching Enzyme (bifunctional):
- Transferase activity: moves 3 of the 4 remaining residues to another chain
- Glucosidase activity: releases the last ฮฑ-1,6 branch residue as FREE glucose (not G1P!)
- Glucose-1-P โ Glucose-6-P (Phosphoglucomutase)
- In liver/kidney: Glucose-6-phosphatase โ Free glucose โ blood
In muscle: No G6Pase โ G6P enters glycolysis directly
Hormonal Regulation
| State | Liver | Muscle |
|---|
| After meal (insulin โ) | Glycogen synthesis โ | Glycogen synthesis โ |
| Fasting (glucagon โ) | Glycogen degradation โ | Little change (fasting) |
| Exercise/Stress (epinephrine โ) | Glycogen degradation โ | Glycogen degradation โ |
| Exercise (Ca2+, AMP โ) | - | Glycogen degradation โ (AMP activates phosphorylase) |
Mechanism of Glucagon/Epinephrine:
Glucagon/Epinephrine โ GPCR โ adenylyl cyclase โ โcAMP โ Protein Kinase A (PKA) โ phosphorylates:
- Glycogen Phosphorylase Kinase โ activates
- Glycogen Phosphorylase โ ACTIVE (phosphorylated = active)
- Glycogen Synthase โ INACTIVE (phosphorylated = inactive)
Result: Glycogen breakdown ON, glycogen synthesis OFF
Insulin does the opposite via phosphatases (dephosphorylation = glycogen synthase active, phosphorylase inactive).
Glycogen Storage Diseases (GSDs) - High Yield
| Type | Name | Deficient Enzyme | Features |
|---|
| I | Von Gierke | Glucose-6-phosphatase | Severe fasting hypoglycemia, huge liver, lactic acidosis, hyperuricemia, hyperlipidemia |
| II | Pompe | Lysosomal acid ฮฑ-glucosidase (GAA) | Cardiomegaly in infants, muscle weakness; "Cardiomegaly = Pompe" |
| III | Cori | Debranching enzyme | Moderate hypoglycemia, liver enlargement; gluconeogenesis intact (unlike Type I) |
| IV | Andersen | Branching enzyme | Abnormal (long, unbranched) glycogen accumulates; liver cirrhosis |
| V | McArdle | Muscle glycogen phosphorylase | Muscle cramps on exercise, myoglobinuria, NO rise in blood lactate with exercise (classic test!) |
| VI | Hers | Liver glycogen phosphorylase | Mild fasting hypoglycemia, liver enlargement; relatively benign |
Clinical pearl - McArdle's ischemic forearm test:
- Ask patient to exercise forearm with tourniquet (no blood flow)
- Normal: Lactate rises, ammonia rises
- McArdle: Lactate does NOT rise (muscle can't break down glycogen to make pyruvate/lactate) but ammonia rises
- Myalgia, cramps, fatigue during exercise are typical symptoms
PART 10: PENTOSE PHOSPHATE PATHWAY (HMP SHUNT / Hexose Monophosphate Shunt)
Location: Cytosol
NOT for ATP production - instead produces:
- NADPH (for biosynthesis and antioxidant defense)
- Ribose-5-phosphate (for nucleotide synthesis - DNA, RNA, ATP, NAD+, etc.)
Where it's most active: Liver (fatty acid synthesis), adrenal cortex (steroid synthesis), RBCs (antioxidant defense), lactating breast (fatty acid synthesis), rapidly dividing cells (nucleotide synthesis)
Two Phases:
Phase 1: Oxidative Phase (Irreversible) - Makes NADPH
- Glucose-6-P โ 6-Phosphoglucono-ฮด-lactone (G6PD - makes NADPH)
- 6-Phosphoglucono-ฮด-lactone โ 6-Phosphogluconate (Lactonase)
- 6-Phosphogluconate โ Ribulose-5-P + CO2 (6-Phosphogluconate dehydrogenase - makes NADPH)
Net from oxidative phase: 1 Glucose-6-P โ 1 Ribulose-5-P + 2 NADPH + 1 CO2
Phase 2: Non-Oxidative Phase (Reversible) - Makes/uses Ribose-5-P
- Ribulose-5-P can be converted to Ribose-5-P (by isomerase) for nucleotide synthesis
- OR if nucleotides not needed, Ribose-5-P can be converted back to glycolytic intermediates (F6P and GAP) via transketolase and transaldolase reactions (these need thiamine/B1 as cofactor!)
Why NADPH is so Important
Role in RBCs (Most testable!):
- H2O2 builds up in RBCs from oxidative metabolism
- Glutathione peroxidase destroys H2O2 using reduced glutathione (GSH)
- GSH gets oxidized to GSSG (disulfide form)
- Glutathione reductase regenerates GSH using NADPH
- HMP shunt is the ONLY source of NADPH in RBCs (no mitochondria, no malic enzyme)
- Without NADPH โ cannot regenerate GSH โ H2O2 accumulates โ oxidizes Hb to Heinz bodies โ RBC membrane damage โ hemolysis
Other roles of NADPH:
- Fatty acid synthesis (cytoplasm)
- Cholesterol/steroid synthesis
- Cytochrome P450 reactions (drug metabolism)
- NADPH oxidase in neutrophils (kills bacteria) - deficient in Chronic Granulomatous Disease
G6PD Deficiency - Most Common Enzyme Defect Worldwide
Genetics: X-linked recessive (mainly males affected)
Prevalence: ~400 million people worldwide; common in Africa, Mediterranean, Middle East
Why common in malaria belt? Heterozygous females have PARTIAL protection against malaria (RBCs infected by Plasmodium lyse faster due to oxidative stress, limiting parasite spread)
Mechanism: Without G6PD โ no NADPH โ no reduced glutathione โ H2O2 destroys Hb โ denatured Hb = Heinz bodies (seen on methyl violet stain) โ RBC hemolysis = Heinz body hemolytic anemia
Triggers of hemolytic crisis:
- Drugs: Primaquine, dapsone, sulfonamides, nitrofurantoin, rasburicase
- Infection (oxidative stress from immune response)
- Fava beans (broad beans - favism) - contain vicine and convicine which generate H2O2
- Naphthalene (mothballs)
Two variants:
| Variant | Population | Enzyme stability | Severity |
|---|
| A- (African) | Afro-Caribbean | Unstable (degrades in old RBCs) | Mild to moderate, self-limiting |
| Mediterranean | Mediterranean/Middle East | Stable but low activity | Severe, can be fatal |
Lab findings during crisis:
- Hemolytic anemia (decreased Hb, increased reticulocytes, increased bilirubin)
- Heinz bodies on peripheral smear
- Decreased G6PD activity (best tested AFTER hemolytic crisis, not during, because young RBCs have higher G6PD activity)
PART 11: CORI CYCLE & GLUCOSE-ALANINE CYCLE
Cori Cycle (Lactate Cycle)
MUSCLE/RBCs LIVER
Glucose โโโ Lactate โโโโโโโโโโโโโโโโโโโ Lactate
โ
Pyruvate
โ (Gluconeogenesis)
Glucose โโโโโโโโโโโโโโโโโโโโโโโโโโโโโ Glucose
- RBCs and anaerobic muscle produce lactate
- Lactate goes to liver via blood
- Liver converts lactate โ pyruvate โ glucose (gluconeogenesis)
- Glucose goes back to muscle/RBCs
- Energy note: Muscle gets 2 ATP from lactate production; liver uses 6 ATP to make glucose. NET: liver subsidizes muscle energy production. The liver makes up the deficit using fat oxidation.
Glucose-Alanine Cycle
MUSCLE LIVER
Pyruvate + NH3 โโโ Alanine โโโโโโโโโโโ Alanine
โ (Transamination)
Pyruvate + NH3
โ โ
Glucose Urea
Glucose โโโโโโโโโโโโโโโโโโโโโโโโโโโโโ Glucose
- During prolonged exercise/fasting, muscle breaks down protein
- Amino acids transaminated to alanine (safe NH3 carrier)
- Alanine sent to liver โ converted back to pyruvate for gluconeogenesis + NH3 goes to urea cycle
- Glucose returns to muscle
PART 12: CLINICAL CONDITIONS - COMPLETE SUMMARY
Inborn Errors of Metabolism
| Disease | Defect | Key Features |
|---|
| Von Gierke (GSD I) | Glucose-6-phosphatase | Fasting hypoglycemia, hepatomegaly, lactic acidosis, hyperuricemia (gout), hyperlipidemia; glucose/fructose/galactose restriction |
| Pompe (GSD II) | Acid ฮฑ-glucosidase (lysosomal) | Infant: Cardiomegaly, hypotonia, early death; Adult: Muscle weakness. Rx: Alglucosidase alfa (enzyme replacement) |
| Cori (GSD III) | Debranching enzyme | Milder than Type I; gluconeogenesis intact; liver + muscle |
| McArdle (GSD V) | Muscle phosphorylase | Exercise intolerance, myoglobinuria; no lactate rise with ischemic exercise test |
| G6PD deficiency | G6PD | Hemolytic anemia with oxidative triggers; Heinz bodies |
| Pyruvate Kinase deficiency | Pyruvate kinase | Chronic hemolytic anemia (not triggered) |
| PDC deficiency | E1-alpha of PDC | Lactic acidosis, neurological damage; Rx: ketogenic diet |
| MODY Type 2 | Glucokinase mutation | Mild, stable hyperglycemia; doesn't need treatment usually |
Toxin/Drug Effects
| Agent | Mechanism | Effect |
|---|
| Cyanide | Blocks Complex IV | Histotoxic hypoxia - cells can't use O2; Rx: Hydroxocobalamin / sodium thiosulfate |
| CO | Blocks Complex IV + Hb | Cherry-red skin; headache, coma; Rx: 100% O2 |
| Arsenic (trivalent) | Inhibits lipoic acid (in PDC, ฮฑ-KGD) | Lactic acidosis, peripheral neuropathy |
| Fluoride | Inhibits enolase (step 9 glycolysis) | Used in glucose collection tubes |
| Metformin | Mild Complex I inhibition | Inhibits gluconeogenesis; used in T2DM; risk of lactic acidosis in renal failure |
Hormonal Regulation - One-Page Summary
| Hormone | Glycolysis | Gluconeogenesis | Glycogenesis | Glycogenolysis |
|---|
| Insulin (fed) | โ | โ | โ | โ |
| Glucagon (fasting) | โ | โ | โ | โ |
| Epinephrine (stress) | โ (muscle) | โ (liver) | โ | โ |
| Cortisol (stress) | - | โ (induces enzymes) | - | - |
๐ฏ MASTER MNEMONIC SHEET
10 Steps of Glycolysis - "Good Gracious! Father Franklin Did Go By Plane, Eventually"
- Glucose โ G6P (Hexokinase)
- G6P โ F6P (Phosphoglucose isomerase)
- F6P โ F1,6-bisP (PFK-1)
- F1,6-bisP โ DHAP + GAP (Aldolase)
- DHAP โ GAP (Triose phosphate isomerase)
- GAP โ 1,3-BPG (GAPDH - NADH)
- BPG โ 3PG (Phosphoglycerate Kinase - ATP)
- PG โ 2PG (Phosphoglycerate Mutase)
- Enolase: 2PG โ PEP
- PEP โ Pyruvate (Pyruvate Kinase - ATP)
TCA Cycle - "Citrate Is Krebs' Starting Substrate For Making Oxaloacetate"
- Citrate (Citrate synthase)
- Isocitrate (Aconitase)
- Ketoglutarate = ฮฑ-KG (Isocitrate dehydrogenase - NADH, CO2)
- Succinyl-CoA (ฮฑ-KG dehydrogenase - NADH, CO2)
- Succinate (Succinyl-CoA synthetase - GTP)
- Fumarate (Succinate dehydrogenase - FADH2)
- Malate (Fumarase)
- Oxaloacetate (Malate dehydrogenase - NADH)
Irreversible Glycolysis Steps - "HoPKins CaFe"
- Hexokinase / Glucokinase
- PFK-1
- Pyruvate Kinase
PDC Cofactors - "The Lovely Cat Found Napping"
Thiamine, Lipoate, CoA, FAD, NAD+
GSDs - "Very Poor Cow Always Makes Lots"
- Von Gierke (I), Pompe (II), Cori (III), Anderson (IV), McArdle (V), Liver phosphorylase/Hers (VI)
All content sourced from: Lippincott Illustrated Biochemistry 8e, Basic Medical Biochemistry 6e, Harper's Illustrated Biochemistry 32e
---Yeh lo - Carbohydrate Metabolism ke Complete Detailed MBBS Notes - sab kuch cover kar diya! ๐ฏ
Quick Summary - Kya Kya Cover Kiya:
| # | Topic | Details |
|---|
| 1 | Glucose Transport | GLUT 1-5 differences, SGLT mechanism, clinical drugs |
| 2 | Glycolysis | All 10 steps, each enzyme, regulation, clinical (arsenic, fluoride, PK deficiency, MODY) |
| 3 | Pyruvate Fate | Aerobic vs anaerobic, 3 possible fates |
| 4 | PDC | Structure (E1/E2/E3), cofactors (B1,B2,B3,B5,Lipoate), regulation, PDC deficiency, Wernicke's |
| 5 | TCA Cycle | All 8 steps, each enzyme, NADH/FADH2/GTP yield, anaplerosis |
| 6 | ETC & Oxidative Phosphorylation | All 4 complexes, chemiosmotic theory, inhibitors (cyanide, CO, rotenone), uncouplers |
| 7 | Total ATP | 30-32 ATP, why not 38 |
| 8 | Gluconeogenesis | 4 precursors, 3 bypass enzymes (Pyruvate Carboxylase, PEPCK, FBPase, G6Pase), regulation |
| 9 | Glycogen Metabolism | Synthesis, degradation, all 6 GSDs with features and treatment |
| 10 | Pentose Phosphate | NADPH, Ribose-5P, G6PD deficiency, Heinz bodies, favism, two variants |
| 11 | Cori & Alanine cycles | Complete pathways |
| 12 | Clinical Summary | All diseases + hormonal regulation table |
Koi bhi concept aur acha samajhna ho - mechanisms, diagrams, ya MCQ practice - batao! ๐